2014
DOI: 10.2131/jts.39.311
|View full text |Cite
|
Sign up to set email alerts
|

Tributyltin induces cell cycle arrest at G1 phase in the yeast <i>Saccharomyces cerevisiae</i>

Abstract: -Tributyltin (TBT) has long been recognized as a major environmental pollutant that can cause significant damage to the cellular functions as well as disruption of endocrine homeostasis. TBT induces apoptosis accompanied by production of reactive oxygen species (ROS) in mammalian and yeast cells. We observed that the budding yeast cells exposed to this compound at low concentrations exhibited cell growth arrest, but not cell death. Flow cytometric analysis of yeast cells without synchronization and morphologic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…To further study the dependence of the MAPK pathway on IP-1-induced cell death, we induced cell cycle arrest of MATα cells using cell cycle inhibitors that do not target the pheromone pathway, but do activate the MAPK pathway. Specifically, we used nocodazole to synchronize cells in the M phase and activate the MAPK pathway ( Hayne et al, 2000 ) and tributyltin (TBT) to shift the cell cycle arrest induced by nocodazole to G 0 /G 1 ( Sekito et al, 2014 ) in MATα cells, which do not express the pheromone receptor (see section “Materials and Methods”). We validated the inhibition of growth of MATα cells treated with each cell cycle inhibitor and we included MATa cells in these experiments as positive controls for IP-1 cytotoxicity (see Supplementary Figure S6 ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…To further study the dependence of the MAPK pathway on IP-1-induced cell death, we induced cell cycle arrest of MATα cells using cell cycle inhibitors that do not target the pheromone pathway, but do activate the MAPK pathway. Specifically, we used nocodazole to synchronize cells in the M phase and activate the MAPK pathway ( Hayne et al, 2000 ) and tributyltin (TBT) to shift the cell cycle arrest induced by nocodazole to G 0 /G 1 ( Sekito et al, 2014 ) in MATα cells, which do not express the pheromone receptor (see section “Materials and Methods”). We validated the inhibition of growth of MATα cells treated with each cell cycle inhibitor and we included MATa cells in these experiments as positive controls for IP-1 cytotoxicity (see Supplementary Figure S6 ).…”
Section: Resultsmentioning
confidence: 99%
“…Cells were grown in 4 mL YPD at 30°C at 250 rpm in constant agitation for 16 h; they were then diluted with YPD to an optical density of 0.12 at 600 nm. The culture was grown to an optical density of 0.4 and then treated with 15 μg/mL nocodazole for 2 h. Cells treated with nocodazole were arrested in G 0 /G 1 phase using 5 μM TBT (tributyltin) for 2 h; it has been reported that under such conditions over 90% of the population was in G 1 /G 0 phase ( Sekito et al, 2014 ). Samples were taken for analysis of cell cycle and viability as described in Sections “FUN1 Viability Assay” and “Cell Cycle Analysis.”…”
Section: Methodsmentioning
confidence: 99%
“…However, they also become important during the response to toxic chemicals, which can produce ROS directly, or else indirectly through metabolism and attempted detoxification in the vacuole. Toxicity of chemicals that produce ROS in the cell may be mitigated through treatment with antioxidants or intensified through damage to the cellular stress networks (Couto et al, 2016;Sekito et al, 2014).…”
Section: Introductionmentioning
confidence: 99%